1. Home
  2. NUVL vs FR Comparison

NUVL vs FR Comparison

Compare NUVL & FR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$123.60

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Logo First Industrial Realty Trust Inc.

FR

First Industrial Realty Trust Inc.

HOLD

Current Price

$61.56

Market Cap

8.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
FR
Founded
2017
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
8.4B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
NUVL
FR
Price
$123.60
$61.56
Analyst Decision
Strong Buy
Buy
Analyst Count
16
12
Target Price
$134.75
$62.17
AVG Volume (30 Days)
4.2M
1.0M
Earning Date
05-08-2026
04-22-2026
Dividend Yield
N/A
3.26%
EPS Growth
N/A
N/A
EPS
N/A
1.08
Revenue
N/A
$727,076,000.00
Revenue This Year
N/A
$11.27
Revenue Next Year
$1,239.49
$7.19
P/E Ratio
N/A
$56.78
Revenue Growth
N/A
8.58
52 Week Low
$71.14
$47.38
52 Week High
$123.69
$64.66

Technical Indicators

Market Signals
Indicator
NUVL
FR
Relative Strength Index (RSI) 66.56 46.04
Support Level $98.56 $59.83
Resistance Level $123.62 $63.85
Average True Range (ATR) 0.21 1.35
MACD -0.05 -0.11
Stochastic Oscillator 82.41 31.47

Price Performance

Historical Comparison
NUVL
FR

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About FR First Industrial Realty Trust Inc.

First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.

Share on Social Networks: